We make the invisible visible
Since 19 November, twelve beamlines at MAX IV are taking light, which is a record number in the facility’s history. The former MAX-lab, which closed in 2015, had at the most eleven beamlines up and running. MAX IV has now, with a little over three years going since the first beamline went into operation surpassed
On Thursday November 14, the team at the CoSAXS beamline detected the first monochromatic light, a crucial step in the beamline commissioning activities. The CoSAXS beamline, set to become an advanced multipurpose Small Angle X-ray Scattering (SAXS) instrument, reached an critical landmark last week when the team detected the first monochromatic light. This detection
image: Researcher Saeed Saedy demonstrates his work with the HIPPIE beamline. The Swedish Institute (SI) offered a scholarship-based training programme at MAX IV in 2019 for researchers from the eight Middle Eastern countries affiliated with SESAME—Synchotron-light for Experimental Science and Applications in the Middle East—light source located in Jordan. During the autumn, two visiting
image: Researcher Neama Imam in the Balder beamline control room. The Swedish Institute (SI) offered a scholarship-based training programme at MAX IV in 2019 for researchers from the eight Middle Eastern countries affiliated with SESAME—Synchrotron-light for Experimental Science and Applications in the Middle East—light source located in Jordan. During the autumn, two visiting researchers
image (from left): Balder Beamline Scientist Kajsa Sigfridsson Clauss and Researcher Martin Magnuson adjust settings on the beamline. In operation since September, Balder beamline has taken its first users to investigate MXenes, a class of nano-crystalline 2D-layered transition metal carbides, carbonitrides and nitrides. Researchers aim to learn more about their fascinating characteristics and how
At October 31, 2019, the BioMAX team performed together with AstraZeneca the first 8-hour remote operation experiment. The researchers from AstraZeneca in Mölndal connected successfully to the BioMAX beamline remotely (left picture) and collected data from many samples during their 8-hour beamtime. Ana Gonzalez from the BioMAX team observed together with Helena Käck from AstraZeneca